Showing results (1-10 of 32) with videos related to
Sort By:
Pageof 4
Revue Medicale De Liege|June 3, 2022
[Inflammation, obesity and type 2 diabetes. Role of the NLRP3 inflammasome and gut microbiota]N Esser, N PaquotRevue Medicale De Liege|May 27, 2010
[Fitness versus fatness: respective cardiometabolic impacts at different age ranges]N Esser, N Paquot, A J ScheenRevue Medicale Suisse|October 7, 2011
[Type 2 diabetes and anti-inflammatory agents: new therapeutic prospects?]N Esser, N Paquot, A J ScheenActa Clinica Belgica|June 24, 2015
Inflammatory markers and cardiometabolic diseasesN Esser, N Paquot, A J ScheenDiabetes & Metabolism|March 22, 2015
Antidiabetic agents: Potential anti-inflammatory activity beyond glucose controlA J Scheen, N Esser, N PaquotJournal of Synchrotron Radiation|February 26, 2009
Dielectric properties of (NH(4))(2)SO(4) crystals in the range of electronic excitationsB Andriyevsky, C Cobet, A Patryn, et al.Revue Medicale Suisse|September 24, 2009
[Metabolically obese normal-weight individuals and metabolically healthy, but obese, subjects]E Beck, N Esser, N Paquot, et al.Biomedical Microdevices|May 17, 2008
Design of an implantable active microport system for patient specific drug releaseA Geipel, F Goldschmidtboeing, P Jantscheff, et al.Revue Medicale De Liege|March 24, 2015
[NLRP3 inflammasome and visceral adipose tissue]N Esser, S Legrand-Poels, J Piette, et al.Pageof 4